Royal London Asset Management
ALNY icon

Royal London Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$84.5M Sell
259,071
-27,872
-10% -$9.09M 0.19% 102
2025
Q1
$77.5M Buy
286,943
+5,434
+2% +$1.47M 0.18% 104
2024
Q4
$66.2M Buy
281,509
+1,759
+0.6% +$414K 0.16% 109
2024
Q3
$76.9M Sell
279,750
-2,595
-0.9% -$714K 0.19% 100
2024
Q2
$68.6M Sell
282,345
-44,524
-14% -$10.8M 0.18% 98
2024
Q1
$48.9M Buy
326,869
+18,045
+6% +$2.7M 0.12% 146
2023
Q4
$59.1M Buy
308,824
+2,229
+0.7% +$427K 0.17% 114
2023
Q3
$54.3M Buy
306,595
+142,357
+87% +$25.2M 0.18% 110
2023
Q2
$31.2M Buy
164,238
+39,467
+32% +$7.5M 0.1% 163
2023
Q1
$25M Buy
124,771
+82,693
+197% +$16.6M 0.1% 171
2022
Q4
$9.99M Buy
42,078
+1,436
+4% +$341K 0.04% 325
2022
Q3
$8.13M Sell
40,642
-1,769
-4% -$354K 0.04% 337
2022
Q2
$6.19M Buy
42,411
+851
+2% +$124K 0.03% 400
2022
Q1
$6.79M Buy
41,560
+1,257
+3% +$205K 0.03% 424
2021
Q4
$6.84M Sell
40,303
-977
-2% -$166K 0.03% 425
2021
Q3
$7.8M Sell
41,280
-1,112
-3% -$210K 0.03% 380
2021
Q2
$7.18M Hold
42,392
0.03% 417
2021
Q1
$5.99M Buy
42,392
+756
+2% +$107K 0.03% 441
2020
Q4
$5.42M Sell
41,636
-1,047
-2% -$136K 0.03% 428
2020
Q3
$6.19M Buy
42,683
+1,975
+5% +$286K 0.04% 345
2020
Q2
$6.03M Hold
40,708
0.04% 344
2020
Q1
$4.43M Hold
40,708
0.04% 393
2019
Q4
$4.67M Buy
40,708
+751
+2% +$86.1K 0.03% 446
2019
Q3
$3.21M Buy
39,957
+2,919
+8% +$235K 0.02% 515
2019
Q2
$2.69M Buy
37,038
+744
+2% +$54K 0.03% 456
2019
Q1
$3.39M Sell
36,294
-30,509
-46% -$2.85M 0.03% 516
2018
Q4
$4.7M Buy
66,803
+9,566
+17% +$673K 0.04% 421
2018
Q3
$5.01M Buy
57,237
+85
+0.1% +$7.44K 0.05% 339
2018
Q2
$5.63M Buy
+57,152
New +$5.63M 0.06% 348
2016
Q2
$3.91M Sell
70,380
-1,057,076
-94% -$58.7M 0.06% 320
2016
Q1
$18K Buy
1,127,456
+1,057,409
+1,510% +$16.9K 0.03% 480
2015
Q4
$6.62M Buy
70,047
+1,789
+3% +$169K 0.1% 208
2015
Q3
$5.49M Buy
+68,258
New +$5.49M 0.09% 242
2014
Q4
$26.7K Sell
27,500
-1,300
-5% -$1.26K 0.05% 380
2014
Q3
$2.26M Hold
28,800
0.06% 350
2014
Q2
$1.65M Buy
28,800
+3,400
+13% +$195K 0.04% 456
2014
Q1
$1.46M Buy
+25,400
New +$1.46M 0.03% 491